Evolutionary analysis of human immunodeficiency virus type 1 therapies based on conditionally replicating vectors.
Efforts to reduce the viral load of human immunodeficiency virus type 1 (HIV-1) during long-term treatment are challenged by the evolution of anti-viral resistance mutants. Recent studies have shown that gene therapy approaches based on conditionally replicating vectors (CRVs) could have many advant...
Guardado en:
Autores principales: | Ruian Ke, James O Lloyd-Smith |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a34b565a0fb4c28b7d77b569d94daaa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human Immunodeficiency Virus Type 2: The Neglected Threat
por: Giancarlo Ceccarelli, et al.
Publicado: (2021) -
Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
por: Eun-Young Kim, et al.
Publicado: (2014) -
Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy
por: von Hentig N
Publicado: (2015) -
In vivo Serial Passaging of Human–Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication
por: Rajesh Thippeshappa, et al.
Publicado: (2021) -
Assessment of oral health and prevalence of oral conditions in human immunodeficiency virus-infected subjects visiting antiretroviral therapy centers
por: Wagisha Barbi, et al.
Publicado: (2021)